Accera to Present at Upcoming Healthcare and Investor Conferences
September 26, 2016
Boulder, Colo., Sept. 26, 2016 – Accera, Inc., a clinical-stage biotechnology company focused on product development for Alzheimer's disease, today announced that the company will present at the following upcoming investor conferences:
- 16th Annual Biotech in Europe Forum: Dr. Charles Stacey, president and CEO, will present an overview of the company on Tuesday, September 27, at 4 p.m. CEST at the Congress Center in Basel, Switzerland. Dr. Stacey will also participate in an Alzheimer's disease panel at 2 p.m. CEST on the same day. The panel includes representatives from Novartis Institutes for BioMedical Research, Eli Lilly and Company, SV Life Sciences, Alzheimer's Research UK and Heptares Therapeutics.
- Neuro Advance Boston: Dr. Stacey will moderate a panel discussion, "Novel Approaches to Alzheimer's Disease," on Wednesday, October 5, at 9:30 a.m. EDT at the Harvard Medical School's Joseph B. Martin Conference Center in Boston. The panel includes representatives from EIP Pharma, vTv Therapeutics, AZTherapies, M3 Biotechnology, and Neurocentria.